A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokenetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta 7

  • De Villiers, Willem (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date11/1/08 → 10/31/10